BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

Fintel reports that on January 7, 2025, BTIG initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy recommendation.

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Penumbra (PEN – Research Report) yesterday and set a price target of $270.00. The ...

BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, ...

BTIG Research has recently reduced Vuzix Corp (VUZI) stock to Neutral rating, as announced on November 10, 2023, according to Finviz. Earlier, on December 21, 2021, Dawson James had initiated the ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus recommendation of “Hold” from the twenty ...

GAMMA Investing LLC increased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 67.6% during the 4th ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

Short seller Hindenburg Research accused Carvana of accounting manipulation and unstable loans. The company denies the ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...